Study NCT00631800
Information provided by Biosynexus Incorporated
First Received: February 29, 2008
No Changes Posted
| This study has been completed. |
|
November 2004
|
|
March 2004 (Final data collection date for primary outcome measure)
|
No publications provided by Biosynexus Incorporated
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Weisman LE, Thackray HM, Steinhorn RH, Walsh WF, Lassiter HA, Dhanireddy R, Brozanski BS, Palmer KG, Trautman MS, Escobedo M, Meissner HC, Sasidharan P, Fretz J, Kokai-Kun JF, Kramer WG, Fischer GW, Mond JJ. A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis. Pediatrics. 2011 Aug;128(2):271-9. Epub 2011 Jul 25.